Showing results (81-90 of 162) with videos related to
Sort By:
Pageof 17
World Journal of Urology|August 11, 2020
Timing and delay of radical prostatectomy do not lead to adverse oncologic outcomes: results from a large European cohort at the times of COVID-19 pandemicRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.BJU International|February 23, 2023
Teaching robotic cystectomy: prospective pilot clinical validation of the ERUS training curriculumRomain Diamand, Frederiek D'Hondt, Georges Mjaess, et al.Urologic Oncology|October 12, 2020
Stratifying patients with intermediate-risk prostate cancer: Validation of a new model based on MRI parameters and targeted biopsy and comparison with NCCN and AUA subclassificationsRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.Journal of Clinical Medicine|May 11, 2024
Variation in Follow-Up after Radical Cystectomy for Bladder Cancer-An Inventory Roundtable and Literature ReviewRoberto Contieri, Renate Pichler, Francesco Del Giudice, et al.European Urology|October 7, 2020
External Validation of a Multiparametric Magnetic Resonance Imaging-based Nomogram for the Prediction of Extracapsular Extension and Seminal Vesicle Invasion in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Guillaume Ploussard, Mathieu Roumiguié, et al.World Journal of Urology|July 3, 2015
The morbidity of laparoscopic radical cystectomy: analysis of postoperative complications in a multicenter cohort by the European Association of Urology (EAU)-Section of Uro-TechnologySimone Albisinni, Marco Oderda, Laurent Fossion, et al.The Journal of Urology|January 23, 2016
Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUTSimone Albisinni, Laurent Fossion, Marco Oderda, et al.World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.The Prostate|January 27, 2023
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.Pageof 17